nodes	percent_of_prediction	percent_of_DWPC	metapath
Entecavir—Immunodeficiency—Methotrexate—ankylosing spondylitis	0.0576	0.0576	CcSEcCtD
Entecavir—Hepatic cirrhosis—Methotrexate—ankylosing spondylitis	0.0521	0.0521	CcSEcCtD
Entecavir—Hepatomegaly—Prednisolone—ankylosing spondylitis	0.0232	0.0232	CcSEcCtD
Entecavir—Hepatomegaly—Triamcinolone—ankylosing spondylitis	0.0214	0.0214	CcSEcCtD
Entecavir—Hepatomegaly—Methylprednisolone—ankylosing spondylitis	0.0213	0.0213	CcSEcCtD
Entecavir—Hepatomegaly—Dexamethasone—ankylosing spondylitis	0.0194	0.0194	CcSEcCtD
Entecavir—Hepatomegaly—Betamethasone—ankylosing spondylitis	0.0194	0.0194	CcSEcCtD
Entecavir—Glycosuria—Triamcinolone—ankylosing spondylitis	0.0187	0.0187	CcSEcCtD
Entecavir—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.0186	0.0186	CcSEcCtD
Entecavir—Glycosuria—Dexamethasone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Entecavir—Glycosuria—Betamethasone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Entecavir—Hepatomegaly—Prednisone—ankylosing spondylitis	0.0169	0.0169	CcSEcCtD
Entecavir—Glycosuria—Prednisone—ankylosing spondylitis	0.0147	0.0147	CcSEcCtD
Entecavir—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.0123	0.0123	CcSEcCtD
Entecavir—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.0113	0.0113	CcSEcCtD
Entecavir—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Entecavir—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.0103	0.0103	CcSEcCtD
Entecavir—Pancreatitis—Prednisolone—ankylosing spondylitis	0.0101	0.0101	CcSEcCtD
Entecavir—Pancreatitis—Triamcinolone—ankylosing spondylitis	0.0093	0.0093	CcSEcCtD
Entecavir—Pancreatitis—Methylprednisolone—ankylosing spondylitis	0.00928	0.00928	CcSEcCtD
Entecavir—Upper respiratory tract infection—Triamcinolone—ankylosing spondylitis	0.00882	0.00882	CcSEcCtD
Entecavir—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00806	0.00806	CcSEcCtD
Entecavir—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00776	0.00776	CcSEcCtD
Entecavir—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00776	0.00776	CcSEcCtD
Entecavir—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.00749	0.00749	CcSEcCtD
Entecavir—Pancreatitis—Prednisone—ankylosing spondylitis	0.00735	0.00735	CcSEcCtD
Entecavir—Neutropenia—Prednisone—ankylosing spondylitis	0.00701	0.00701	CcSEcCtD
Entecavir—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00684	0.00684	CcSEcCtD
Entecavir—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00676	0.00676	CcSEcCtD
Entecavir—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00664	0.00664	CcSEcCtD
Entecavir—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00659	0.00659	CcSEcCtD
Entecavir—Pancreatitis—Methotrexate—ankylosing spondylitis	0.00614	0.00614	CcSEcCtD
Entecavir—Alopecia—Betamethasone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Entecavir—Alopecia—Dexamethasone—ankylosing spondylitis	0.00609	0.00609	CcSEcCtD
Entecavir—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00587	0.00587	CcSEcCtD
Entecavir—Neutropenia—Methotrexate—ankylosing spondylitis	0.00586	0.00586	CcSEcCtD
Entecavir—Upper respiratory tract infection—Methotrexate—ankylosing spondylitis	0.00582	0.00582	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00558	0.00558	CcSEcCtD
Entecavir—Renal failure—Methotrexate—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Entecavir—Immune system disorder—Prednisone—ankylosing spondylitis	0.00542	0.00542	CcSEcCtD
Entecavir—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.00539	0.00539	CcSEcCtD
Entecavir—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00538	0.00538	CcSEcCtD
Entecavir—Infection—Triamcinolone—ankylosing spondylitis	0.00536	0.00536	CcSEcCtD
Entecavir—Infection—Methylprednisolone—ankylosing spondylitis	0.00535	0.00535	CcSEcCtD
Entecavir—Haematuria—Methotrexate—ankylosing spondylitis	0.00533	0.00533	CcSEcCtD
Entecavir—Insomnia—Prednisolone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Entecavir—Alopecia—Prednisone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Entecavir—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00528	0.00528	CcSEcCtD
Entecavir—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00528	0.00528	CcSEcCtD
Entecavir—Mental disorder—Prednisone—ankylosing spondylitis	0.00526	0.00526	CcSEcCtD
Entecavir—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00523	0.00523	CcSEcCtD
Entecavir—Malnutrition—Prednisone—ankylosing spondylitis	0.00522	0.00522	CcSEcCtD
Entecavir—Hepatitis—Methotrexate—ankylosing spondylitis	0.00501	0.00501	CcSEcCtD
Entecavir—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Entecavir—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.00489	0.00489	CcSEcCtD
Entecavir—Insomnia—Triamcinolone—ankylosing spondylitis	0.00488	0.00488	CcSEcCtD
Entecavir—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00487	0.00487	CcSEcCtD
Entecavir—Infection—Betamethasone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Entecavir—Infection—Dexamethasone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Entecavir—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Entecavir—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.0048	0.0048	CcSEcCtD
Entecavir—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00475	0.00475	CcSEcCtD
Entecavir—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00474	0.00474	CcSEcCtD
Entecavir—Fatigue—Triamcinolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Entecavir—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00464	0.00464	CcSEcCtD
Entecavir—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00453	0.00453	CcSEcCtD
Entecavir—Alopecia—Methotrexate—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Entecavir—Insomnia—Dexamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Entecavir—Insomnia—Betamethasone—ankylosing spondylitis	0.00443	0.00443	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00442	0.00442	CcSEcCtD
Entecavir—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Entecavir—Mental disorder—Methotrexate—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Entecavir—Malnutrition—Methotrexate—ankylosing spondylitis	0.00436	0.00436	CcSEcCtD
Entecavir—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Entecavir—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00431	0.00431	CcSEcCtD
Entecavir—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Entecavir—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Entecavir—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Entecavir—Infection—Prednisone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Entecavir—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Entecavir—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00423	0.00423	CcSEcCtD
Entecavir—Fatigue—Dexamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Entecavir—Fatigue—Betamethasone—ankylosing spondylitis	0.00422	0.00422	CcSEcCtD
Entecavir—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00418	0.00418	CcSEcCtD
Entecavir—Skin disorder—Prednisone—ankylosing spondylitis	0.00414	0.00414	CcSEcCtD
Entecavir—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Entecavir—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Entecavir—Leukopenia—Methotrexate—ankylosing spondylitis	0.00391	0.00391	CcSEcCtD
Entecavir—Dizziness—Prednisolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Entecavir—Asthenia—Triamcinolone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Entecavir—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Entecavir—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Entecavir—Body temperature increased—Betamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Entecavir—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.00387	0.00387	CcSEcCtD
Entecavir—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Entecavir—Insomnia—Prednisone—ankylosing spondylitis	0.00385	0.00385	CcSEcCtD
Entecavir—Dyspepsia—Prednisone—ankylosing spondylitis	0.00375	0.00375	CcSEcCtD
Entecavir—Rash—Prednisolone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Entecavir—Dermatitis—Prednisolone—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Entecavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.00369	0.00369	CcSEcCtD
Entecavir—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Entecavir—Fatigue—Prednisone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Entecavir—Headache—Prednisolone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Entecavir—Dizziness—Triamcinolone—ankylosing spondylitis	0.00357	0.00357	CcSEcCtD
Entecavir—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Entecavir—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00356	0.00356	CcSEcCtD
Entecavir—Infection—Methotrexate—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Entecavir—Asthenia—Dexamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Entecavir—Asthenia—Betamethasone—ankylosing spondylitis	0.00351	0.00351	CcSEcCtD
Entecavir—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Entecavir—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00349	0.00349	CcSEcCtD
Entecavir—Nausea—Prednisolone—ankylosing spondylitis	0.00348	0.00348	CcSEcCtD
Entecavir—Skin disorder—Methotrexate—ankylosing spondylitis	0.00346	0.00346	CcSEcCtD
Entecavir—Vomiting—Triamcinolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Entecavir—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00342	0.00342	CcSEcCtD
Entecavir—Rash—Triamcinolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Entecavir—Dermatitis—Triamcinolone—ankylosing spondylitis	0.0034	0.0034	CcSEcCtD
Entecavir—Rash—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Entecavir—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.00339	0.00339	CcSEcCtD
Entecavir—Headache—Triamcinolone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Entecavir—Headache—Methylprednisolone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Entecavir—Abdominal pain—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Entecavir—Body temperature increased—Prednisone—ankylosing spondylitis	0.00337	0.00337	CcSEcCtD
Entecavir—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Entecavir—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Entecavir—Dizziness—Betamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Entecavir—Dizziness—Dexamethasone—ankylosing spondylitis	0.00324	0.00324	CcSEcCtD
Entecavir—Insomnia—Methotrexate—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Entecavir—Nausea—Triamcinolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Entecavir—Nausea—Methylprednisolone—ankylosing spondylitis	0.0032	0.0032	CcSEcCtD
Entecavir—Somnolence—Methotrexate—ankylosing spondylitis	0.00317	0.00317	CcSEcCtD
Entecavir—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00314	0.00314	CcSEcCtD
Entecavir—Vomiting—Dexamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Entecavir—Vomiting—Betamethasone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Entecavir—Rash—Dexamethasone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Entecavir—Rash—Betamethasone—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Entecavir—Dermatitis—Dexamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Entecavir—Dermatitis—Betamethasone—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Entecavir—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Entecavir—Fatigue—Methotrexate—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Entecavir—Headache—Dexamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Entecavir—Headache—Betamethasone—ankylosing spondylitis	0.00307	0.00307	CcSEcCtD
Entecavir—Asthenia—Prednisone—ankylosing spondylitis	0.00306	0.00306	CcSEcCtD
Entecavir—Diarrhoea—Prednisone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Entecavir—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Entecavir—Nausea—Betamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Entecavir—Nausea—Dexamethasone—ankylosing spondylitis	0.00291	0.00291	CcSEcCtD
Entecavir—Dizziness—Prednisone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Entecavir—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Entecavir—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Entecavir—Vomiting—Prednisone—ankylosing spondylitis	0.00271	0.00271	CcSEcCtD
Entecavir—Rash—Prednisone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Entecavir—Dermatitis—Prednisone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Entecavir—Headache—Prednisone—ankylosing spondylitis	0.00267	0.00267	CcSEcCtD
Entecavir—Asthenia—Methotrexate—ankylosing spondylitis	0.00256	0.00256	CcSEcCtD
Entecavir—Nausea—Prednisone—ankylosing spondylitis	0.00253	0.00253	CcSEcCtD
Entecavir—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Entecavir—Dizziness—Methotrexate—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Entecavir—Vomiting—Methotrexate—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Entecavir—Rash—Methotrexate—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Entecavir—Dermatitis—Methotrexate—ankylosing spondylitis	0.00224	0.00224	CcSEcCtD
Entecavir—Headache—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Entecavir—Nausea—Methotrexate—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
